Hypertension and Its Role in Cognitive Function: Current Evidence and Challenges for the Future

Timothy M Hughes1, Kaycee M Sink2

  • 1Department of Internal Medicine, Division of Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.

Insights

High blood pressure, particularly in midlife, is linked to cognitive decline and dementia. While observational studies suggest hypertension treatment may prevent dementia, clinical trials show mixed results, necessitating further research with biomarkers.

Area of Science:

  • Neurology
  • Cardiology
  • Gerontology

Background:

  • Elevated blood pressure, especially midlife hypertension, is associated with cognitive decline and dementia.
  • Hypertension impacts brain structure, contributing to small vessel disease and vascular dementia.
  • Hypertension interacts with Alzheimer's pathology, potentially lowering the threshold for symptom manifestation.

Purpose of the Study:

  • To review evidence on blood pressure, dementia biomarkers, and cognitive health.
  • To highlight challenges in randomized trials of hypertension and cognition.
  • To propose future research directions for understanding hypertension's role in cognitive decline.

Main Methods:

  • Review of observational studies linking blood pressure to cognitive decline and dementia.
  • Analysis of studies on hypertension's effects on brain structure and small vessel disease.
  • Examination of randomized trials of antihypertensive therapy with cognitive endpoints.

Main Results:

  • Observational data strongly suggest elevated blood pressure is linked to cognitive decline and dementia.
  • Hypertension is associated with brain changes like small vessel disease and Alzheimer's biomarkers (beta-amyloid, tau).
  • Randomized trials of antihypertensive therapy have not consistently supported cognitive benefits.

Conclusions:

  • Despite strong biological plausibility, randomized trials do not fully support observational findings on hypertension treatment for cognitive benefits.
  • Future trials should incorporate dementia biomarkers and assess genetic/cardiometabolic risk factors.
  • Further research is needed to reconcile observational and trial data for effective hypertension management in cognitive health.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
714
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
647
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.2K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
836